Search Results - "Georgakis, Georgios V."

Refine Results
  1. 1

    Design and radiosynthesis of class-IIa HDAC inhibitor with high molar activity via repositioning the 18F-radiolabel by Xu, Sulan, Huang, Chun-Han, Eyermann, Christopher, Georgakis, Georgios V., Turkman, Nashaat

    Published in Scientific reports (02-07-2024)
    “…The design and radiosynthesis of [ 18 F]NT376, a high potency inhibitor of class-IIa histone deacetylases (HDAC) is reported. We utilized a three-step…”
    Get full text
    Journal Article
  2. 2

    Development of a Radiolabeled Cyclin-Dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Brain and Cancer PET Imaging by Huang, Chun-Han, Khan, Palwasha, Xu, Sulan, Cohen, Jules, Georgakis, Georgios V, Turkman, Nashaat

    “…The synthesis, biochemical evaluation and radiosynthesis of a cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitor and radioligand was performed. NT431, a newly…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines by Buglio, Daniela, Georgakis, Georgios V., Hanabuchi, Shino, Arima, Kazuhiko, Khaskhely, Noor M., Liu, Yong-Jun, Younes, Anas

    Published in Blood (15-08-2008)
    “…Epigenetic changes have been implicated in silencing several B-cell genes in Hodgkin and Reed-Sternberg cells (HRS) of Hodgkin lymphoma (HL), and this…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma by Georgakis, Georgios V., Li, Yang, Rassidakis, Georgios Z., Medeiros, L. Jeffrey, Mills, Gordon B., Younes, Anas

    Published in British journal of haematology (01-02-2006)
    “…Summary Activation of the phosphatidylinositol 3‐kinase (PI3K) pathway has been linked with tumour cell growth, survival and resistance to therapy in several…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer by Gao, Mei, Lin, Miranda, Moffitt, Richard A., Salazar, Marcela A., Park, Jinha, Vacirca, Jeffrey, Huang, Chuan, Shroyer, Kenneth R., Choi, Minsig, Georgakis, Georgios V., Sasson, Aaron R., Talamini, Mark A., Kim, Joseph

    Published in British journal of cancer (08-01-2019)
    “…Background Pancreatic cancer (PC) hijacks innate cellular processes to promote cancer growth. We hypothesized that PC exploits PD-1/PD-L1 not only to avoid…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma by Yazbeck, Victor Y, Buglio, Daniela, Georgakis, Georgios V, Li, Yang, Iwado, Eiji, Romaguera, Jorge E, Kondo, Seiji, Younes, Anas

    Published in Experimental hematology (01-04-2008)
    “…Objective To investigate the mechanisms of antiproliferative effect induced by the mammalian target of rapamycin (mTOR) inhibitor temsirolimus in mantle cell…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Prognostic significance of serum B-lymphocyte stimulator level in Hodgkin's lymphoma by Oki, Yasuhiro, Georgakis, Georgios V, Migone, Thi-Sau, Kwak, Larry W, Younes, Anas

    Published in Haematologica (Roma) (01-02-2007)
    “…Department of Lymphoma and Myeloma, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, 77030 and Department of Clinical Immunoassays, Human…”
    Get full text
    Journal Article
  16. 16

    The heat shock protein 90 inhibitor 17‐AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9 by Georgakis, Georgios V., Li, Yang, Younes, Anas

    Published in British journal of haematology (01-10-2006)
    “…Summary Mantle cell lymphoma (MCL), a distinct type of non‐Hodgkin lymphoma, is characterised by the overexpression of cyclin D1. Heat shock protein 90 (HSP90)…”
    Get full text
    Journal Article
  17. 17

    Case report of intestinal non-rotation, heterotaxy, and polysplenia in a patient with pancreatic cancer by Pagkratis, Spyridon, Kryeziu, Sara, Lin, Miranda, Hoque, Samah, Bucobo, Juan Carlos, Buscaglia, Jonathan M., Georgakis, Georgios V., Sasson, Aaron R., Kim, Joseph

    Published in Medicine (Baltimore) (01-12-2017)
    “…Heterotaxy with polysplenia is an extremely rare congenital condition resulting from abnormal arrangement of organs in the abdominal and thoracic cavities…”
    Get full text
    Journal Article
  18. 18

    From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy by Georgakis, Georgios V, Younes, Anas

    Published in Expert review of anticancer therapy (01-01-2006)
    “…One of the most prominent pathways explored in the area of targeted therapy is the PI3K/Akt/mTOR pathway, which plays a central role in cell survival and…”
    Get full text
    Journal Article
  19. 19

    Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond by Georgakis, Georgios V, Younes, Anas

    Published in Future oncology (London, England) (01-04-2005)
    “…Heat-shock protein 90 (HSP90) has diverse functions in mammalian cells. It acts as molecular chaperone, together with several co-chaperone molecules (such as…”
    Get more information
    Journal Article
  20. 20

    The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression by Georgakis, Georgios V., Li, Yang, Rassidakis, Georgios Z., Medeiros, L. Jeffrey, Younes, Anas

    Published in Experimental hematology (01-12-2006)
    “…Heat shock protein 90 (HSP90) chaperones and maintains the molecular integrity of a variety of signal transduction proteins, including the…”
    Get full text
    Journal Article